,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,266631,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,53354,PANK1,https://ctdbase.org/detail.go?type=gene&acc=53354,,,53354.0,PANK1,9606.0,Homo sapiens (human),Aristolochic acid I results in decreased expression of PANK1 mRNA,,,PMID:33212167,https://www.ncbi.nlm.nih.gov/pubmed/33212167,33212167,,
1,284861,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,5984,RFC4,https://ctdbase.org/detail.go?type=gene&acc=5984,,,5984.0,RFC4,9606.0,Homo sapiens (human),Aristolochic acid I results in decreased expression of RFC4 mRNA,,,PMID:33212167,https://www.ncbi.nlm.nih.gov/pubmed/33212167,33212167,,
2,284862,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,342931,RFPL4A,https://ctdbase.org/detail.go?type=gene&acc=342931,,,342931.0,RFPL4A,9606.0,Homo sapiens (human),Aristolochic acid I results in increased expression of RFPL4A mRNA,,,PMID:33212167,https://www.ncbi.nlm.nih.gov/pubmed/33212167,33212167,,
3,284863,2236,Comparative Toxicogenomics Database (CTD),Aristolochic acid,C000228,aristolochic acid I,https://ctdbase.org/detail.go?type=chem&acc=C000228,130132,RFTN2,https://ctdbase.org/detail.go?type=gene&acc=130132,,,130132.0,RFTN2,9606.0,Homo sapiens (human),Aristolochic acid I results in increased expression of RFTN2 mRNA,,,PMID:33212167,https://www.ncbi.nlm.nih.gov/pubmed/33212167,33212167,,
4,302526,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,6925,TCF4,https://ctdbase.org/detail.go?type=gene&acc=6925,,,6925.0,TCF4,9606.0,Homo sapiens (human),TCF4 protein promotes the reaction [aspirin results in increased susceptibility to TNFSF10 protein],,,PMID:21171083,https://www.ncbi.nlm.nih.gov/pubmed/21171083,21171083,,
5,302527,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,10312,TCIRG1,https://ctdbase.org/detail.go?type=gene&acc=10312,,,10312.0,TCIRG1,9606.0,Homo sapiens (human),Aspirin results in increased expression of TCIRG1 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
6,302528,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606.0,Homo sapiens (human),Aspirin results in increased expression of TERT mRNA,,,PMID:20457246,https://www.ncbi.nlm.nih.gov/pubmed/20457246,20457246,,
7,302529,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of TF protein],,,PMID:17303692,https://www.ncbi.nlm.nih.gov/pubmed/17303692,17303692,,
8,302530,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7019,TFAM,https://ctdbase.org/detail.go?type=gene&acc=7019,,,7019.0,TFAM,10090.0,Mus musculus (house mouse),Aspirin inhibits the reaction [cisplatin results in decreased expression of TFAM protein],,,PMID:37179038,https://www.ncbi.nlm.nih.gov/pubmed/37179038,37179038,,
9,302531,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7030,TFE3,https://ctdbase.org/detail.go?type=gene&acc=7030,,,7030.0,TFE3,9606.0,Homo sapiens (human),Aspirin results in decreased expression of TFE3 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
10,302532,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7032,TFF2,https://ctdbase.org/detail.go?type=gene&acc=7032,,,7032.0,TFF2,10116.0,Rattus norvegicus (Norway rat),[aspirin co-treated with hydrochloric acid] results in increased expression of TFF2 mRNA,,,PMID:9726391,https://www.ncbi.nlm.nih.gov/pubmed/9726391,9726391,,
11,302533,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,10342,TFG,https://ctdbase.org/detail.go?type=gene&acc=10342,,,10342.0,TFG,9606.0,Homo sapiens (human),Aspirin results in increased expression of TFG mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
12,303225,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [lipopolysaccharides results in increased secretion of TNF protein],,,PMID:15379866,https://www.ncbi.nlm.nih.gov/pubmed/15379866,15379866,,
13,303226,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]|aspirin inhibits the reaction [TNF protein results in increased expression of CCND1 protein]|aspirin inhibits the reaction [TNF protein results in increased secretion of dinoprostone]|aspirin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]|aspirin inhibits the reaction [TNF protein results in increased activity of RELA protein]|aspirin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]|aspirin inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]|aspirin inhibits the reaction [TNF protein results in increased abundance of dinoprostone]|aspirin inhibits the reaction [TNF protein results in increased activity of CHUK protein],,,PMID:15489888,https://www.ncbi.nlm.nih.gov/pubmed/15489888,15489888,,
14,303227,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF results in increased degradation of NFKBIA protein]|aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIB protein]|aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIA protein],,,PMID:15036249,https://www.ncbi.nlm.nih.gov/pubmed/15036249,15036249,,
15,303228,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF results in increased secretion of CCL2 protein]|aspirin inhibits the reaction [TNF results in increased secretion of CXCL8 protein]|aspirin inhibits the reaction [TNF results in increased expression of CCL2 mrna]|aspirin inhibits the reaction [TNF results in increased expression of CXCL8 mrna],,,PMID:15136050,https://www.ncbi.nlm.nih.gov/pubmed/15136050,15136050,,
16,303229,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 mrna]|aspirin inhibits the reaction [TNF results in increased expression of PTGS2 protein]|aspirin inhibits the reaction [TNF results in increased expression of CX3CL1 protein]|aspirin inhibits the reaction [TNF results in increased expression of PTGS2 mrna],,,PMID:19493461,https://www.ncbi.nlm.nih.gov/pubmed/19493461,19493461,,
17,303230,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Aspirin promotes the reaction [salmonella vaccines results in increased expression of TNF protein],,,PMID:12045164,https://www.ncbi.nlm.nih.gov/pubmed/12045164,12045164,,
18,303231,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),TNF gene SNP affects the susceptibility to aspirin,,,PMID:20485159,https://www.ncbi.nlm.nih.gov/pubmed/20485159,20485159,,
19,303232,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),TNF polymorphism affects the susceptibility to aspirin,,,PMID:17516296,https://www.ncbi.nlm.nih.gov/pubmed/17516296,17516296,,
20,228782,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55907,CMAS,https://ctdbase.org/detail.go?type=gene&acc=55907,,,55907.0,CMAS,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CMAS mRNA,,,PMID:19770486|PMID:21715664|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|21715664|22228805,,
21,228783,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene affects the splicing of CMBL exon|benzo(a)pyrene results in increased expression of CMBL mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
22,228784,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of CMBL mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
23,228785,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CMBL intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
24,228786,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CMBL mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170|PMID:30453624,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/30453624,20106945|21632981|22316170|30453624,,
25,228787,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CMBL promoter|benzo(a)pyrene results in increased methylation of CMBL 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
26,228788,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,134147,CMBL,https://ctdbase.org/detail.go?type=gene&acc=134147,,,134147.0,CMBL,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CMBL mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
27,228789,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8050,PDHX,https://ctdbase.org/detail.go?type=gene&acc=8050,,,8050.0,PDHX,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDHX promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
28,228790,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,39651,PDI,https://ctdbase.org/detail.go?type=gene&acc=39651,,,39651.0,Pdi,35525.0,Daphnia magna,[benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of PDI mRNA,,,PMID:21632023,https://www.ncbi.nlm.nih.gov/pubmed/21632023,21632023,,
29,288386,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,102857920,GPR98,https://ctdbase.org/detail.go?type=gene&acc=102857920,,,102857920.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of GPR98 5' utr|benzo(a)pyrene affects the methylation of GPR98 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
30,300454,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,13105,CYP2D9,https://ctdbase.org/detail.go?type=gene&acc=13105,,,13105.0,Cyp2d9,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CYP2D9 protein,,,PMID:34472326,https://www.ncbi.nlm.nih.gov/pubmed/34472326,34472326,,
31,300455,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CYP2E1 promoter|benzo(a)pyrene results in increased methylation of CYP2E1 5' utr|benzo(a)pyrene affects the methylation of CYP2E1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
32,300456,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CYP2E1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
33,300769,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,74558,GVIN1,https://ctdbase.org/detail.go?type=gene&acc=74558,,,74558.0,Gvin1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of GVIN1 mRNA,,,PMID:19770486|PMID:21569818|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|21569818|32417428,,
34,300973,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,105264500,GYLTL1B,https://ctdbase.org/detail.go?type=gene&acc=105264500,,,105264500.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of GYLTL1B promoter|benzo(a)pyrene affects the methylation of GYLTL1B 3' utr|benzo(a)pyrene results in increased methylation of GYLTL1B 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
35,300974,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2993,GYPA,https://ctdbase.org/detail.go?type=gene&acc=2993,,,2993.0,GYPA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of GYPA mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
36,300975,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2994,GYPB,https://ctdbase.org/detail.go?type=gene&acc=2994,,,2994.0,GYPB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of GYPB mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
37,300976,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2994,GYPB,https://ctdbase.org/detail.go?type=gene&acc=2994,,,2994.0,GYPB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of GYPB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
38,300977,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2995,GYPC,https://ctdbase.org/detail.go?type=gene&acc=2995,,,2995.0,GYPC,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of GYPC intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
39,300978,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2995,GYPC,https://ctdbase.org/detail.go?type=gene&acc=2995,,,2995.0,GYPC,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of GYPC promoter|benzo(a)pyrene results in decreased methylation of GYPC 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
40,303385,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8970,H2BC11,https://ctdbase.org/detail.go?type=gene&acc=8970,,,8970.0,H2BC11,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H2BC11 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
41,303386,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of H2BC12 promoter|benzo(a)pyrene affects the methylation of H2BC12 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
42,303387,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of H2BC12 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
43,303388,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of H2BC12 protein,,,PMID:33044785,https://www.ncbi.nlm.nih.gov/pubmed/33044785,33044785,,
44,303389,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H2BC12 mRNA,,,PMID:22228805|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/22610609,22228805|22610609,,
45,303585,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CYP8B1 mRNA,,,PMID:20064835|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20064835|26238291|32234424,,
46,228635,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1984,EIF5A,https://ctdbase.org/detail.go?type=gene&acc=1984,,,1984.0,EIF5A,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of EIF5A protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
47,228636,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9669,EIF5B,https://ctdbase.org/detail.go?type=gene&acc=9669,,,9669.0,EIF5B,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of EIF5B mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
48,228637,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1991,ELANE,https://ctdbase.org/detail.go?type=gene&acc=1991,,,1991.0,ELANE,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ELANE mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
49,228638,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,63916,ELMO2,https://ctdbase.org/detail.go?type=gene&acc=63916,,,63916.0,ELMO2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ELMO2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
50,228639,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9694,EMC2,https://ctdbase.org/detail.go?type=gene&acc=9694,,,9694.0,EMC2,10090.0,Mus musculus (house mouse),Erianin inhibits the reaction [dextran sulfate results in decreased expression of EMC2 protein]|dextran sulfate results in decreased expression of EMC2 protein,,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
51,284864,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of CEBPA mRNA,,,PMID:23727198,https://www.ncbi.nlm.nih.gov/pubmed/23727198,23727198,,
52,363542,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9135,RABEP1,https://ctdbase.org/detail.go?type=gene&acc=9135,,,9135.0,RABEP1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RABEP1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
53,363543,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,79874,RABEP2,https://ctdbase.org/detail.go?type=gene&acc=79874,,,79874.0,RABEP2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RABEP2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
54,363544,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,27342,RABGEF1,https://ctdbase.org/detail.go?type=gene&acc=27342,,,27342.0,RABGEF1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RABGEF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
55,300447,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,2185,PTK2B,https://ctdbase.org/detail.go?type=gene&acc=2185,,,2185.0,PTK2B,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PTK2B mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
56,300448,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5753,PTK6,https://ctdbase.org/detail.go?type=gene&acc=5753,,,5753.0,PTK6,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PTK6 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
57,300449,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,7803,PTP4A1,https://ctdbase.org/detail.go?type=gene&acc=7803,,,7803.0,PTP4A1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PTP4A1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
58,300450,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5770,PTPN1,https://ctdbase.org/detail.go?type=gene&acc=5770,,,5770.0,PTPN1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PTPN1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
59,300451,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PTPN2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
60,300452,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PTPRF mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
61,300453,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5817,PVR,https://ctdbase.org/detail.go?type=gene&acc=5817,,,5817.0,PVR,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PVR mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
62,302872,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,10592,SMC2,https://ctdbase.org/detail.go?type=gene&acc=10592,,,10592.0,SMC2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of SMC2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
63,300230,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,262,AMD1,https://ctdbase.org/detail.go?type=gene&acc=262,,,262.0,AMD1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AMD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
64,300231,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AMDHD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
65,300232,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51005,AMDHD2,https://ctdbase.org/detail.go?type=gene&acc=51005,,,51005.0,AMDHD2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AMDHD2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
66,300233,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in decreased expression of AMH mRNA,,,PMID:34571837|PMID:36769379,https://www.ncbi.nlm.nih.gov/pubmed/34571837|https://www.ncbi.nlm.nih.gov/pubmed/36769379,34571837|36769379,,
67,300234,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AMH mRNA,,,PMID:36769379,https://www.ncbi.nlm.nih.gov/pubmed/36769379,36769379,,
68,300235,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AMH protein,,,PMID:34571837,https://www.ncbi.nlm.nih.gov/pubmed/34571837,34571837,,
69,300236,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,269,AMHR2,https://ctdbase.org/detail.go?type=gene&acc=269,,,269.0,AMHR2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AMHR2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
70,300237,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,57463,AMIGO1,https://ctdbase.org/detail.go?type=gene&acc=57463,,,57463.0,AMIGO1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AMIGO1 mRNA,,,PMID:20350560,https://www.ncbi.nlm.nih.gov/pubmed/20350560,20350560,,
71,301123,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,325557,ANXA2A,https://ctdbase.org/detail.go?type=gene&acc=325557,,,325557.0,anxa2a,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of ANXA2A mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
72,301124,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ANXA4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
73,301125,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,9606.0,Homo sapiens (human),Chlorpyrifos results in increased cleavage of ANXA5 protein,,,PMID:24793810,https://www.ncbi.nlm.nih.gov/pubmed/24793810,24793810,,
74,301126,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,308,ANXA5,https://ctdbase.org/detail.go?type=gene&acc=308,,,308.0,ANXA5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ANXA5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
75,301127,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AOC1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
76,301128,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,69761,AOC1L2,https://ctdbase.org/detail.go?type=gene&acc=69761,,,69761.0,Aoc1l2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AOC1L2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
77,301317,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,164,AP1G1,https://ctdbase.org/detail.go?type=gene&acc=164,,,164.0,AP1G1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of AP1G1 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
78,301318,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8906,AP1G2,https://ctdbase.org/detail.go?type=gene&acc=8906,,,8906.0,AP1G2,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos affects the expression of AP1G2 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
79,301319,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AP1M1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
80,301320,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of AP1M1 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
81,301321,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1174,AP1S1,https://ctdbase.org/detail.go?type=gene&acc=1174,,,1174.0,AP1S1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AP1S1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
82,301322,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,161,AP2A2,https://ctdbase.org/detail.go?type=gene&acc=161,,,161.0,AP2A2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AP2A2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
83,301323,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,163,AP2B1,https://ctdbase.org/detail.go?type=gene&acc=163,,,163.0,AP2B1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AP2B1 mRNA,,,PMID:20350560|PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/20350560|https://www.ncbi.nlm.nih.gov/pubmed/32715474,20350560|32715474,,
84,301324,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1173,AP2M1,https://ctdbase.org/detail.go?type=gene&acc=1173,,,1173.0,AP2M1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AP2M1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
85,301650,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of DIO2 mrna|[chlorpyrifos co-treated with triiodothyronine] results in decreased expression of DIO2 mRNA,,,PMID:34571837,https://www.ncbi.nlm.nih.gov/pubmed/34571837,34571837,,
86,301651,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,10090.0,Mus musculus (house mouse),Chlorpyrifos affects the expression of DIO3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
87,301652,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1735,DIO3,https://ctdbase.org/detail.go?type=gene&acc=1735,,,1735.0,DIO3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DIO3 protein|chlorpyrifos results in decreased expression of DIO3 mrna|chlorpyrifos results in increased expression of DIO3 mRNA,,,PMID:34571837,https://www.ncbi.nlm.nih.gov/pubmed/34571837,34571837,,
88,301653,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,100538339,DIO3A,https://ctdbase.org/detail.go?type=gene&acc=100538339,,,100538339.0,dio3a,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in decreased expression of DIO3A mRNA,,,PMID:36769379,https://www.ncbi.nlm.nih.gov/pubmed/36769379,36769379,,
89,301654,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,798872,DIO3B,https://ctdbase.org/detail.go?type=gene&acc=798872,,,798872.0,dio3b,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in decreased expression of DIO3B mRNA,,,PMID:34571837|PMID:36769379,https://www.ncbi.nlm.nih.gov/pubmed/34571837|https://www.ncbi.nlm.nih.gov/pubmed/36769379,34571837|36769379,,
90,301655,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,798872,DIO3B,https://ctdbase.org/detail.go?type=gene&acc=798872,,,798872.0,dio3b,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of DIO3B mRNA,,,PMID:32738127|PMID:34748799,https://www.ncbi.nlm.nih.gov/pubmed/32738127|https://www.ncbi.nlm.nih.gov/pubmed/34748799,32738127|34748799,,
91,301656,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,798872,DIO3B,https://ctdbase.org/detail.go?type=gene&acc=798872,,,798872.0,dio3b,7955.0,Danio rerio (zebrafish),[ethylenethiourea co-treated with chlorpyrifos] results in increased expression of DIO3B mRNA,,,PMID:32738127,https://www.ncbi.nlm.nih.gov/pubmed/32738127,32738127,,
92,302208,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,28194,APON,https://ctdbase.org/detail.go?type=gene&acc=28194,,,28194.0,Apon,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of APON mRNA,,,PMID:32715474|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/32715474|https://www.ncbi.nlm.nih.gov/pubmed/37019170,32715474|37019170,,
93,302209,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,79135,APOO,https://ctdbase.org/detail.go?type=gene&acc=79135,,,79135.0,APOO,7962.0,Cyprinus carpio (common carp),Chlorpyrifos results in decreased expression of APOO mRNA,,,PMID:28648885,https://www.ncbi.nlm.nih.gov/pubmed/28648885,28648885,,
94,302534,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8128,ST8SIA2,https://ctdbase.org/detail.go?type=gene&acc=8128,,,8128.0,ST8SIA2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ST8SIA2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
95,302535,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51046,ST8SIA3,https://ctdbase.org/detail.go?type=gene&acc=51046,,,51046.0,ST8SIA3,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of ST8SIA3 mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
96,302536,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23166,STAB1,https://ctdbase.org/detail.go?type=gene&acc=23166,,,23166.0,STAB1,7962.0,Cyprinus carpio (common carp),Chlorpyrifos results in increased expression of STAB1 mRNA,,,PMID:28648885,https://www.ncbi.nlm.nih.gov/pubmed/28648885,28648885,,
97,303223,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,346673,STRA8,https://ctdbase.org/detail.go?type=gene&acc=346673,,,346673.0,STRA8,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of STRA8 mRNA,,,PMID:30378422|PMID:34571837,https://www.ncbi.nlm.nih.gov/pubmed/30378422|https://www.ncbi.nlm.nih.gov/pubmed/34571837,30378422|34571837,,
98,303224,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,92335,STRADA,https://ctdbase.org/detail.go?type=gene&acc=92335,,,92335.0,STRADA,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of STRADA mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
99,304769,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,569642,TAC3B,https://ctdbase.org/detail.go?type=gene&acc=569642,,,569642.0,tac3b,7955.0,Danio rerio (zebrafish),[copper co-treated with chlorpyrifos] results in increased expression of TAC3B mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
100,304770,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,255061,TAC4,https://ctdbase.org/detail.go?type=gene&acc=255061,,,255061.0,TAC4,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of TAC4 mRNA,,,PMID:20682304,https://www.ncbi.nlm.nih.gov/pubmed/20682304,20682304,,
101,299675,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2110,ETFDH,https://ctdbase.org/detail.go?type=gene&acc=2110,,,2110.0,ETFDH,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in decreased expression of ETFDH protein,,,PMID:20118634,https://www.ncbi.nlm.nih.gov/pubmed/20118634,20118634,,
102,299676,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2110,ETFDH,https://ctdbase.org/detail.go?type=gene&acc=2110,,,2110.0,ETFDH,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in increased expression of ETFDH protein,,,PMID:16470657,https://www.ncbi.nlm.nih.gov/pubmed/16470657,16470657,,
103,299677,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,23474,ETHE1,https://ctdbase.org/detail.go?type=gene&acc=23474,,,23474.0,ETHE1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of ETHE1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ETHE1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
104,299678,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,55224,ETNK2,https://ctdbase.org/detail.go?type=gene&acc=55224,,,55224.0,ETNK2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of ETNK2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
105,299679,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2114,ETS2,https://ctdbase.org/detail.go?type=gene&acc=2114,,,2114.0,ETS2,9541.0,Macaca fascicularis (crab-eating macaque),Clofibrate results in decreased expression of ETS2 mRNA,,,PMID:16081524,https://www.ncbi.nlm.nih.gov/pubmed/16081524,16081524,,
106,299680,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2114,ETS2,https://ctdbase.org/detail.go?type=gene&acc=2114,,,2114.0,ETS2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ETS2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of ETS2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
107,299681,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2123,EVI2A,https://ctdbase.org/detail.go?type=gene&acc=2123,,,2123.0,EVI2A,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of EVI2A mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of EVI2A mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
108,299682,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,54512,EXOSC4,https://ctdbase.org/detail.go?type=gene&acc=54512,,,54512.0,EXOSC4,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of EXOSC4 mRNA,,,PMID:17585979|PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/17585979|https://www.ncbi.nlm.nih.gov/pubmed/25270620,17585979|25270620,,
109,299683,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of EXOSC5 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
110,301325,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,26998,FETUB,https://ctdbase.org/detail.go?type=gene&acc=26998,,,26998.0,FETUB,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in decreased expression of FETUB mRNA,,,PMID:12851107,https://www.ncbi.nlm.nih.gov/pubmed/12851107,12851107,,
111,301326,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,55079,FEZF2,https://ctdbase.org/detail.go?type=gene&acc=55079,,,55079.0,FEZF2,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of FEZF2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
112,301327,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2244,FGB,https://ctdbase.org/detail.go?type=gene&acc=2244,,,2244.0,FGB,9541.0,Macaca fascicularis (crab-eating macaque),Clofibrate results in increased expression of FGB protein,,,PMID:9869165,https://www.ncbi.nlm.nih.gov/pubmed/9869165,9869165,,
113,303739,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2780,GNAT2,https://ctdbase.org/detail.go?type=gene&acc=2780,,,2780.0,GNAT2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GNAT2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of GNAT2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
114,303740,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2783,GNB2,https://ctdbase.org/detail.go?type=gene&acc=2783,,,2783.0,GNB2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GNB2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
115,303741,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,10020,GNE,https://ctdbase.org/detail.go?type=gene&acc=10020,,,10020.0,GNE,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GNE mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GNE mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
116,303742,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,10020,GNE,https://ctdbase.org/detail.go?type=gene&acc=10020,,,10020.0,GNE,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GNE mRNA,,,PMID:17585979|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17585979|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17585979|23811191,,
117,303743,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2794,GNL1,https://ctdbase.org/detail.go?type=gene&acc=2794,,,2794.0,GNL1,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GNL1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
118,303744,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,26354,GNL3,https://ctdbase.org/detail.go?type=gene&acc=26354,,,26354.0,GNL3,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GNL3 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of GNL3 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
119,303745,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,27232,GNMT,https://ctdbase.org/detail.go?type=gene&acc=27232,,,27232.0,GNMT,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GNMT mrna]|[clofibrate co-treated with acetaminophen] affects the expression of GNMT mrna|clofibrate results in decreased expression of GNMT mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
120,303746,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,10007,GNPDA1,https://ctdbase.org/detail.go?type=gene&acc=10007,,,10007.0,GNPDA1,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GNPDA1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
121,303925,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,55105,GPATCH2,https://ctdbase.org/detail.go?type=gene&acc=55105,,,55105.0,GPATCH2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GPATCH2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
122,303926,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,55668,GPATCH2L,https://ctdbase.org/detail.go?type=gene&acc=55668,,,55668.0,GPATCH2L,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GPATCH2L mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
123,303927,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,151306,GPBAR1,https://ctdbase.org/detail.go?type=gene&acc=151306,,,151306.0,GPBAR1,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GPBAR1 mRNA,,,PMID:29175453,https://www.ncbi.nlm.nih.gov/pubmed/29175453,29175453,,
124,304111,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2820,GPD2,https://ctdbase.org/detail.go?type=gene&acc=2820,,,2820.0,GPD2,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GPD2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
125,304112,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2822,GPLD1,https://ctdbase.org/detail.go?type=gene&acc=2822,,,2822.0,GPLD1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GPLD1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GPLD1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
126,314674,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,4185,ADAM11,https://ctdbase.org/detail.go?type=gene&acc=4185,,,4185.0,ADAM11,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of ADAM11 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
127,314675,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8751,ADAM15,https://ctdbase.org/detail.go?type=gene&acc=8751,,,8751.0,ADAM15,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of ADAM15 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ADAM15 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
128,301469,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,605,BCL7A,https://ctdbase.org/detail.go?type=gene&acc=605,,,605.0,BCL7A,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of BCL7A mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
129,303037,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Amphetamine results in decreased activity of CAT protein,,,PMID:19799584,https://www.ncbi.nlm.nih.gov/pubmed/19799584,19799584,,
130,303038,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CAV1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
131,303039,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,8436,CAVIN2,https://ctdbase.org/detail.go?type=gene&acc=8436,,,8436.0,CAVIN2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CAVIN2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
132,303040,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,863,CBFA2T3,https://ctdbase.org/detail.go?type=gene&acc=863,,,863.0,CBFA2T3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBFA2T3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
133,303041,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,867,CBL,https://ctdbase.org/detail.go?type=gene&acc=867,,,867.0,CBL,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBL mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
134,303042,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,84733,CBX2,https://ctdbase.org/detail.go?type=gene&acc=84733,,,84733.0,CBX2,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBX2 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
135,303043,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,8535,CBX4,https://ctdbase.org/detail.go?type=gene&acc=8535,,,8535.0,CBX4,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBX4 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
136,303044,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,23466,CBX6,https://ctdbase.org/detail.go?type=gene&acc=23466,,,23466.0,CBX6,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBX6 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
137,303045,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,23492,CBX7,https://ctdbase.org/detail.go?type=gene&acc=23492,,,23492.0,CBX7,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CBX7 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
138,303046,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,92922,CCDC102A,https://ctdbase.org/detail.go?type=gene&acc=92922,,,92922.0,CCDC102A,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CCDC102A mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
139,295006,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,65993,MRPS34,https://ctdbase.org/detail.go?type=gene&acc=65993,,,65993.0,MRPS34,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of MRPS34 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
140,299684,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8508,NIPSNAP1,https://ctdbase.org/detail.go?type=gene&acc=8508,,,8508.0,NIPSNAP1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of NIPSNAP1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
141,301851,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,4902,NRTN,https://ctdbase.org/detail.go?type=gene&acc=4902,,,4902.0,NRTN,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of NRTN mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
142,302026,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,51251,NT5C3A,https://ctdbase.org/detail.go?type=gene&acc=51251,,,51251.0,NT5C3A,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of NT5C3A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
143,302027,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,115024,NT5C3B,https://ctdbase.org/detail.go?type=gene&acc=115024,,,115024.0,NT5C3B,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of NT5C3B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
144,302028,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,64943,NT5DC2,https://ctdbase.org/detail.go?type=gene&acc=64943,,,64943.0,NT5DC2,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of NT5DC2 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
145,301470,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,91319,DERL3,https://ctdbase.org/detail.go?type=gene&acc=91319,,,91319.0,DERL3,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of DERL3 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
146,301471,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1676,DFFA,https://ctdbase.org/detail.go?type=gene&acc=1676,,,1676.0,DFFA,9606.0,Homo sapiens (human),Diclofenac affects the expression of DFFA mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
147,301472,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1718,DHCR24,https://ctdbase.org/detail.go?type=gene&acc=1718,,,1718.0,DHCR24,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of DHCR24 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
148,301473,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1719,DHFR,https://ctdbase.org/detail.go?type=gene&acc=1719,,,1719.0,DHFR,9606.0,Homo sapiens (human),Diclofenac affects the expression of DHFR mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
149,301474,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,79154,DHRS11,https://ctdbase.org/detail.go?type=gene&acc=79154,,,79154.0,DHRS11,9986.0,Oryctolagus cuniculus (rabbit),Diclofenac results in decreased activity of DHRS11 protein,,,PMID:30926317,https://www.ncbi.nlm.nih.gov/pubmed/30926317,30926317,,
150,301475,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,9249,DHRS3,https://ctdbase.org/detail.go?type=gene&acc=9249,,,9249.0,DHRS3,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of DHRS3 mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
151,301476,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,22943,DKK1,https://ctdbase.org/detail.go?type=gene&acc=22943,,,22943.0,DKK1,9606.0,Homo sapiens (human),Diclofenac affects the expression of DKK1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
152,301477,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,3301,DNAJA1,https://ctdbase.org/detail.go?type=gene&acc=3301,,,3301.0,DNAJA1,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJA1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
153,301478,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,10294,DNAJA2,https://ctdbase.org/detail.go?type=gene&acc=10294,,,10294.0,DNAJA2,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJA2 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
154,301479,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,9093,DNAJA3,https://ctdbase.org/detail.go?type=gene&acc=9093,,,9093.0,DNAJA3,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJA3 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
155,302200,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10090.0,Mus musculus (house mouse),Diclofenac inhibits the reaction [EDN1 protein results in decreased transport of potassium],,,PMID:15083534,https://www.ncbi.nlm.nih.gov/pubmed/15083534,15083534,,
156,302201,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,29904,EEF2K,https://ctdbase.org/detail.go?type=gene&acc=29904,,,29904.0,EEF2K,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of EEF2K mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
157,302202,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of EGF protein,,,PMID:23506792,https://www.ncbi.nlm.nih.gov/pubmed/23506792,23506792,,
158,302203,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of EGFR mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
159,302204,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),Diclofenac results in increased expression of EGR1 mRNA,,,PMID:15509713,https://www.ncbi.nlm.nih.gov/pubmed/15509713,15509713,,
160,302205,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10090.0,Mus musculus (house mouse),Diclofenac affects the expression of EGR1 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
161,302206,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,9606.0,Homo sapiens (human),Diclofenac affects the expression of EIF1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
162,302207,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,13664,EIF1A,https://ctdbase.org/detail.go?type=gene&acc=13664,,,13664.0,Eif1a,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of EIF1A mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
163,256488,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7022,TFAP2C,https://ctdbase.org/detail.go?type=gene&acc=7022,,,7022.0,TFAP2C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of TFAP2C mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
164,288387,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2271,FH,https://ctdbase.org/detail.go?type=gene&acc=2271,,,2271.0,FH,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FH mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
165,288388,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2271,FH,https://ctdbase.org/detail.go?type=gene&acc=2271,,,2271.0,FH,9606.0,Homo sapiens (human),Valproic acid affects the expression of FH mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
166,288389,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2271,FH,https://ctdbase.org/detail.go?type=gene&acc=2271,,,2271.0,FH,9606.0,Homo sapiens (human),Valproic acid results in increased expression of FH mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|26272509|29154799,,
167,299109,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,151613,TTC14,https://ctdbase.org/detail.go?type=gene&acc=151613,,,151613.0,TTC14,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of TTC14 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
168,299110,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,158248,TTC16,https://ctdbase.org/detail.go?type=gene&acc=158248,,,158248.0,TTC16,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of TTC16 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
169,299111,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55761,TTC17,https://ctdbase.org/detail.go?type=gene&acc=55761,,,55761.0,TTC17,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
170,299525,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85443,DCLK3,https://ctdbase.org/detail.go?type=gene&acc=85443,,,85443.0,DCLK3,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DCLK3 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
171,299526,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9937,DCLRE1A,https://ctdbase.org/detail.go?type=gene&acc=9937,,,9937.0,DCLRE1A,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DCLRE1A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
172,299527,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64858,DCLRE1B,https://ctdbase.org/detail.go?type=gene&acc=64858,,,64858.0,DCLRE1B,9606.0,Homo sapiens (human),Valproic acid affects the expression of DCLRE1B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
173,299528,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64858,DCLRE1B,https://ctdbase.org/detail.go?type=gene&acc=64858,,,64858.0,DCLRE1B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DCLRE1B mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
174,299529,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64421,DCLRE1C,https://ctdbase.org/detail.go?type=gene&acc=64421,,,64421.0,DCLRE1C,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of DCLRE1C mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
175,299530,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64421,DCLRE1C,https://ctdbase.org/detail.go?type=gene&acc=64421,,,64421.0,DCLRE1C,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of DCLRE1C mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
176,299531,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64421,DCLRE1C,https://ctdbase.org/detail.go?type=gene&acc=64421,,,64421.0,DCLRE1C,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DCLRE1C mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
177,299532,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,284900,TTC28-AS1,https://ctdbase.org/detail.go?type=gene&acc=284900,,,284900.0,TTC28-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of TTC28-AS1 mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|25192806|26272509,,
178,299868,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of NR2C2 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
179,299869,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,126382,NR2C2AP,https://ctdbase.org/detail.go?type=gene&acc=126382,,,126382.0,NR2C2AP,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NR2C2AP mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
180,299870,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,126382,NR2C2AP,https://ctdbase.org/detail.go?type=gene&acc=126382,,,126382.0,NR2C2AP,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NR2C2AP gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
181,299871,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7101,NR2E1,https://ctdbase.org/detail.go?type=gene&acc=7101,,,7101.0,NR2E1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of NR2E1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
182,300043,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in decreased expression of NR2F1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
183,300044,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441094,NR2F1-AS1,https://ctdbase.org/detail.go?type=gene&acc=441094,,,441094.0,NR2F1-AS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F1-AS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
184,300045,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441094,NR2F1-AS1,https://ctdbase.org/detail.go?type=gene&acc=441094,,,441094.0,NR2F1-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NR2F1-AS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
185,300046,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441094,NR2F1-AS1,https://ctdbase.org/detail.go?type=gene&acc=441094,,,441094.0,NR2F1-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NR2F1-AS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
186,300047,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441094,NR2F1-AS1,https://ctdbase.org/detail.go?type=gene&acc=441094,,,441094.0,NR2F1-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NR2F1-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
187,300048,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7026,NR2F2,https://ctdbase.org/detail.go?type=gene&acc=7026,,,7026.0,NR2F2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2F2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
188,300049,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7026,NR2F2,https://ctdbase.org/detail.go?type=gene&acc=7026,,,7026.0,NR2F2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NR2F2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
189,300617,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142.0,DCUN1D4,9606.0,Homo sapiens (human),Valproic acid affects the expression of DCUN1D4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
190,300618,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142.0,DCUN1D4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DCUN1D4 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
191,300619,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142.0,DCUN1D4,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DCUN1D4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
192,300620,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23142,DCUN1D4,https://ctdbase.org/detail.go?type=gene&acc=23142,,,23142.0,DCUN1D4,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DCUN1D4 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
193,300621,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84259,DCUN1D5,https://ctdbase.org/detail.go?type=gene&acc=84259,,,84259.0,DCUN1D5,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DCUN1D5 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
194,300622,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84259,DCUN1D5,https://ctdbase.org/detail.go?type=gene&acc=84259,,,84259.0,DCUN1D5,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DCUN1D5 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
195,300623,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641.0,DCX,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCX mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
196,300624,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641.0,DCX,9606.0,Homo sapiens (human),Valproic acid affects the expression of DCX mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
197,300625,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1641,DCX,https://ctdbase.org/detail.go?type=gene&acc=1641,,,1641.0,DCX,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DCX gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
198,300626,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,769389,DDEFL1,https://ctdbase.org/detail.go?type=gene&acc=769389,,,769389.0,DDEFL1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DDEFL1 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
199,300968,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1428,CRYM,https://ctdbase.org/detail.go?type=gene&acc=1428,,,1428.0,CRYM,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CRYM mRNA,,,PMID:19101580|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|28001369|29154799,,
200,300969,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,34604,CRYS,https://ctdbase.org/detail.go?type=gene&acc=34604,,,34604.0,Crys,7227.0,Drosophila melanogaster (fruit fly),[valproic acid co-treated with pentylenetetrazole] affects the expression of CRYS mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
201,300970,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CRYZ mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
202,300971,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CRYZ mRNA,,,PMID:19101580|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|28001369,,
203,300972,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9946,CRYZL1,https://ctdbase.org/detail.go?type=gene&acc=9946,,,9946.0,CRYZL1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CRYZL1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
204,301646,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51299,NRN1,https://ctdbase.org/detail.go?type=gene&acc=51299,,,51299.0,NRN1,9606.0,Homo sapiens (human),CEBPA protein affects the reaction [valproic acid results in increased expression of NRN1 mrna],,,PMID:32623605,https://www.ncbi.nlm.nih.gov/pubmed/32623605,32623605,,
205,301647,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51299,NRN1,https://ctdbase.org/detail.go?type=gene&acc=51299,,,51299.0,NRN1,9606.0,Homo sapiens (human),Valproic acid affects the expression of NRN1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
206,301648,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51299,NRN1,https://ctdbase.org/detail.go?type=gene&acc=51299,,,51299.0,NRN1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NRN1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
207,301649,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51299,NRN1,https://ctdbase.org/detail.go?type=gene&acc=51299,,,51299.0,NRN1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NRN1 mRNA,,,PMID:28001369|PMID:32623605,https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/32623605,28001369|32623605,,
208,301841,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8829,NRP1,https://ctdbase.org/detail.go?type=gene&acc=8829,,,8829.0,NRP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
209,301842,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8829,NRP1,https://ctdbase.org/detail.go?type=gene&acc=8829,,,8829.0,NRP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NRP1 mRNA,,,PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,28001369|29154799,,
210,301843,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8829,NRP1,https://ctdbase.org/detail.go?type=gene&acc=8829,,,8829.0,NRP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NRP1 mRNA,,,PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24383497|26272509|28001369,,
211,301844,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8829,NRP1,https://ctdbase.org/detail.go?type=gene&acc=8829,,,8829.0,NRP1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of NRP1 mRNA,,,PMID:37207908,https://www.ncbi.nlm.nih.gov/pubmed/37207908,37207908,,
212,301845,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
213,301846,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9606.0,Homo sapiens (human),Valproic acid affects the expression of NRP2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
214,301847,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NRP2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
215,301848,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8828,NRP2,https://ctdbase.org/detail.go?type=gene&acc=8828,,,8828.0,NRP2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NRP2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
216,301849,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,405902,NRP2B,https://ctdbase.org/detail.go?type=gene&acc=405902,,,405902.0,nrp2b,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of NRP2B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
217,301850,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375387,NRROS,https://ctdbase.org/detail.go?type=gene&acc=375387,,,375387.0,NRROS,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NRROS gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
218,302360,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,29118,DDX25,https://ctdbase.org/detail.go?type=gene&acc=29118,,,29118.0,DDX25,9606.0,Homo sapiens (human),Valproic acid affects the expression of DDX25 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
219,302361,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,29118,DDX25,https://ctdbase.org/detail.go?type=gene&acc=29118,,,29118.0,DDX25,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DDX25 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
220,302362,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55661,DDX27,https://ctdbase.org/detail.go?type=gene&acc=55661,,,55661.0,DDX27,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of DDX27 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
221,302363,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55794,DDX28,https://ctdbase.org/detail.go?type=gene&acc=55794,,,55794.0,DDX28,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DDX28 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
222,302693,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81566,CSRNP2,https://ctdbase.org/detail.go?type=gene&acc=81566,,,81566.0,CSRNP2,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CSRNP2 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
223,302694,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80034,CSRNP3,https://ctdbase.org/detail.go?type=gene&acc=80034,,,80034.0,CSRNP3,9606.0,Homo sapiens (human),Valproic acid affects the expression of CSRNP3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
224,302695,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80034,CSRNP3,https://ctdbase.org/detail.go?type=gene&acc=80034,,,80034.0,CSRNP3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CSRNP3 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
225,302696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80034,CSRNP3,https://ctdbase.org/detail.go?type=gene&acc=80034,,,80034.0,CSRNP3,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CSRNP3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
226,302697,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80034,CSRNP3,https://ctdbase.org/detail.go?type=gene&acc=80034,,,80034.0,CSRNP3,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of CSRNP3 mrna|valproic acid results in decreased expression of CSRNP3 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
227,302698,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1465,CSRP1,https://ctdbase.org/detail.go?type=gene&acc=1465,,,1465.0,CSRP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
228,302862,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27229,TUBGCP4,https://ctdbase.org/detail.go?type=gene&acc=27229,,,27229.0,TUBGCP4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of TUBGCP4 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
229,302863,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27229,TUBGCP4,https://ctdbase.org/detail.go?type=gene&acc=27229,,,27229.0,TUBGCP4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of TUBGCP4 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
230,303381,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4907,NT5E,https://ctdbase.org/detail.go?type=gene&acc=4907,,,4907.0,NT5E,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NT5E mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
231,303382,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4907,NT5E,https://ctdbase.org/detail.go?type=gene&acc=4907,,,4907.0,NT5E,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of NT5E gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
232,303383,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4907,NT5E,https://ctdbase.org/detail.go?type=gene&acc=4907,,,4907.0,NT5E,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NT5E mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
233,303384,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56953,NT5M,https://ctdbase.org/detail.go?type=gene&acc=56953,,,56953.0,NT5M,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NT5M gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
234,303586,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79096,CSTPP1,https://ctdbase.org/detail.go?type=gene&acc=79096,,,79096.0,CSTPP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CSTPP1 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
235,303587,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,541466,CT45A1,https://ctdbase.org/detail.go?type=gene&acc=541466,,,541466.0,CT45A1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CT45A1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
236,303588,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,728911,CT45A2,https://ctdbase.org/detail.go?type=gene&acc=728911,,,728911.0,CT45A2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CT45A2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
237,303589,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441519,CT45A3,https://ctdbase.org/detail.go?type=gene&acc=441519,,,441519.0,CT45A3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CT45A3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
238,303590,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441521,CT45A5,https://ctdbase.org/detail.go?type=gene&acc=441521,,,441521.0,CT45A5,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CT45A5 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
239,303591,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,541465,CT45A6,https://ctdbase.org/detail.go?type=gene&acc=541465,,,541465.0,CT45A6,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CT45A6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
240,303592,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,196993,CT62,https://ctdbase.org/detail.go?type=gene&acc=196993,,,196993.0,CT62,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CT62 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
241,303593,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,246100,CTAG1A,https://ctdbase.org/detail.go?type=gene&acc=246100,,,246100.0,CTAG1A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CTAG1A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
242,303594,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1485,CTAG1B,https://ctdbase.org/detail.go?type=gene&acc=1485,,,1485.0,CTAG1B,9606.0,Homo sapiens (human),Valproic acid promotes the reaction [decitabine results in increased expression of CTAG1B protein]|valproic acid promotes the reaction [decitabine results in increased expression of CTAG1B mrna]|valproic acid promotes the reaction [decitabine results in decreased methylation of CTAG1B promoter],,,PMID:19030781,https://www.ncbi.nlm.nih.gov/pubmed/19030781,19030781,,
243,303595,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1485,CTAG1B,https://ctdbase.org/detail.go?type=gene&acc=1485,,,1485.0,CTAG1B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CTAG1B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
244,304264,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4922,NTS,https://ctdbase.org/detail.go?type=gene&acc=4922,,,4922.0,NTS,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTS mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
245,304265,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4922,NTS,https://ctdbase.org/detail.go?type=gene&acc=4922,,,4922.0,NTS,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NTS mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24383497|24935251|26272509|28001369,,
246,304266,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4922,NTS,https://ctdbase.org/detail.go?type=gene&acc=4922,,,4922.0,NTS,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of NTS mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
247,304267,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4923,NTSR1,https://ctdbase.org/detail.go?type=gene&acc=4923,,,4923.0,NTSR1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of NTSR1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
248,304268,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4923,NTSR1,https://ctdbase.org/detail.go?type=gene&acc=4923,,,4923.0,NTSR1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NTSR1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
249,304269,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4923,NTSR1,https://ctdbase.org/detail.go?type=gene&acc=4923,,,4923.0,NTSR1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of NTSR1 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
250,304270,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23620,NTSR2,https://ctdbase.org/detail.go?type=gene&acc=23620,,,23620.0,NTSR2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in decreased expression of NTSR2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
251,304271,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23620,NTSR2,https://ctdbase.org/detail.go?type=gene&acc=23620,,,23620.0,NTSR2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NTSR2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
252,304427,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115908,CTHRC1,https://ctdbase.org/detail.go?type=gene&acc=115908,,,115908.0,CTHRC1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CTHRC1 mRNA,,,PMID:25716160|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/25716160|https://www.ncbi.nlm.nih.gov/pubmed/29154799,25716160|29154799,,
253,304428,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115908,CTHRC1,https://ctdbase.org/detail.go?type=gene&acc=115908,,,115908.0,CTHRC1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CTHRC1 mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24383497|24935251|26272509|27188386|28001369,,
254,304429,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115908,CTHRC1,https://ctdbase.org/detail.go?type=gene&acc=115908,,,115908.0,CTHRC1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CTHRC1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
255,304430,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9811,CTIF,https://ctdbase.org/detail.go?type=gene&acc=9811,,,9811.0,CTIF,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CTIF mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
256,304431,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9811,CTIF,https://ctdbase.org/detail.go?type=gene&acc=9811,,,9811.0,CTIF,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CTIF mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
257,304432,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9811,CTIF,https://ctdbase.org/detail.go?type=gene&acc=9811,,,9811.0,CTIF,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CTIF mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
258,304433,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1493,CTLA4,https://ctdbase.org/detail.go?type=gene&acc=1493,,,1493.0,CTLA4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CTLA4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
259,304434,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1495,CTNNA1,https://ctdbase.org/detail.go?type=gene&acc=1495,,,1495.0,CTNNA1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CTNNA1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
260,304435,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1496,CTNNA2,https://ctdbase.org/detail.go?type=gene&acc=1496,,,1496.0,CTNNA2,9606.0,Homo sapiens (human),Valproic acid affects the expression of CTNNA2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
261,304436,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1496,CTNNA2,https://ctdbase.org/detail.go?type=gene&acc=1496,,,1496.0,CTNNA2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CTNNA2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
262,304591,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,163486,DENND1B,https://ctdbase.org/detail.go?type=gene&acc=163486,,,163486.0,DENND1B,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DENND1B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
263,304592,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,163486,DENND1B,https://ctdbase.org/detail.go?type=gene&acc=163486,,,163486.0,DENND1B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DENND1B mRNA,,,PMID:24935251|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/29154799,24935251|29154799,,
264,304593,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,163486,DENND1B,https://ctdbase.org/detail.go?type=gene&acc=163486,,,163486.0,DENND1B,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of DENND1B mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
265,304594,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79958,DENND1C,https://ctdbase.org/detail.go?type=gene&acc=79958,,,79958.0,DENND1C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DENND1C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
266,304595,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27147,DENND2A,https://ctdbase.org/detail.go?type=gene&acc=27147,,,27147.0,DENND2A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
267,304596,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27147,DENND2A,https://ctdbase.org/detail.go?type=gene&acc=27147,,,27147.0,DENND2A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DENND2A mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
268,304597,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27147,DENND2A,https://ctdbase.org/detail.go?type=gene&acc=27147,,,27147.0,DENND2A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DENND2A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
269,304598,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6764,DENND2B,https://ctdbase.org/detail.go?type=gene&acc=6764,,,6764.0,DENND2B,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of DENND2B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
270,304599,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6764,DENND2B,https://ctdbase.org/detail.go?type=gene&acc=6764,,,6764.0,DENND2B,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DENND2B mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
271,304600,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6764,DENND2B,https://ctdbase.org/detail.go?type=gene&acc=6764,,,6764.0,DENND2B,10090.0,Mus musculus (house mouse),Valproic acid inhibits the reaction [dexamethasone results in increased expression of DENND2B mrna],,,PMID:23946490,https://www.ncbi.nlm.nih.gov/pubmed/23946490,23946490,,
272,304601,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10907,TXNL4A,https://ctdbase.org/detail.go?type=gene&acc=10907,,,10907.0,TXNL4A,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of TXNL4A mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
273,312528,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,408263,FNDC9,https://ctdbase.org/detail.go?type=gene&acc=408263,,,408263.0,FNDC9,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of FNDC9 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
274,312529,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,96459,FNIP1,https://ctdbase.org/detail.go?type=gene&acc=96459,,,96459.0,FNIP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of FNIP1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
275,327850,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2670,GFAP,https://ctdbase.org/detail.go?type=gene&acc=2670,,,2670.0,GFAP,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of GFAP protein,,,PMID:18585900,https://www.ncbi.nlm.nih.gov/pubmed/18585900,18585900,,
276,327851,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2671,GFER,https://ctdbase.org/detail.go?type=gene&acc=2671,,,2671.0,GFER,9606.0,Homo sapiens (human),Valproic acid affects the expression of GFER mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
277,228969,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10922,FASTK,https://ctdbase.org/detail.go?type=gene&acc=10922,,,10922.0,FASTK,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of FASTK mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,
278,228970,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2192,FBLN1,https://ctdbase.org/detail.go?type=gene&acc=2192,,,2192.0,FBLN1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of FBLN1 mRNA,,,PMID:15205334,https://www.ncbi.nlm.nih.gov/pubmed/15205334,15205334,,
279,228971,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2192,FBLN1,https://ctdbase.org/detail.go?type=gene&acc=2192,,,2192.0,FBLN1,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of FBLN1 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
280,228972,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,26271,FBXO5,https://ctdbase.org/detail.go?type=gene&acc=26271,,,26271.0,FBXO5,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of FBXO5 mRNA,,,PMID:16557594,https://www.ncbi.nlm.nih.gov/pubmed/16557594,16557594,,
281,228973,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,26271,FBXO5,https://ctdbase.org/detail.go?type=gene&acc=26271,,,26271.0,FBXO5,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of FBXO5 mRNA,,,PMID:19272435,https://www.ncbi.nlm.nih.gov/pubmed/19272435,19272435,,
282,228974,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2232,FDXR,https://ctdbase.org/detail.go?type=gene&acc=2232,,,2232.0,FDXR,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of FDXR mRNA,,,PMID:15205334|PMID:16557594|PMID:17982676|PMID:22966307,https://www.ncbi.nlm.nih.gov/pubmed/15205334|https://www.ncbi.nlm.nih.gov/pubmed/16557594|https://www.ncbi.nlm.nih.gov/pubmed/17982676|https://www.ncbi.nlm.nih.gov/pubmed/22966307,15205334|16557594|17982676|22966307,,
283,299862,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,267,AMFR,https://ctdbase.org/detail.go?type=gene&acc=267,,,267.0,AMFR,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of AMFR mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
284,299863,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,10393,ANAPC10,https://ctdbase.org/detail.go?type=gene&acc=10393,,,10393.0,ANAPC10,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ANAPC10 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
285,299864,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,8022.0,Oncorhynchus mykiss (rainbow trout),Indole-3-carbinol results in decreased expression of ANG mRNA,,,PMID:16192472,https://www.ncbi.nlm.nih.gov/pubmed/16192472,16192472,,
286,299865,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,11731,ANG2,https://ctdbase.org/detail.go?type=gene&acc=11731,,,11731.0,Ang2,8022.0,Oncorhynchus mykiss (rainbow trout),Indole-3-carbinol results in decreased expression of ANG2 mRNA,,,PMID:16192472,https://www.ncbi.nlm.nih.gov/pubmed/16192472,16192472,,
287,299866,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of ANGPTL4 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
288,299867,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,118932,ANKRD22,https://ctdbase.org/detail.go?type=gene&acc=118932,,,118932.0,ANKRD22,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ANKRD22 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
289,300050,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,147463,ANKRD29,https://ctdbase.org/detail.go?type=gene&acc=147463,,,147463.0,ANKRD29,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ANKRD29 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
290,300051,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,147463,ANKRD29,https://ctdbase.org/detail.go?type=gene&acc=147463,,,147463.0,ANKRD29,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of ANKRD29 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
291,300052,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,353322,ANKRD37,https://ctdbase.org/detail.go?type=gene&acc=353322,,,353322.0,ANKRD37,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ANKRD37 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
292,300053,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,338699,ANKRD42,https://ctdbase.org/detail.go?type=gene&acc=338699,,,338699.0,ANKRD42,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ANKRD42 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
293,300228,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of AQP1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
294,300229,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Indole-3-carbinol results in decreased activity of AR protein,,,PMID:16082211,https://www.ncbi.nlm.nih.gov/pubmed/16082211,16082211,,
295,300759,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,431705,ASTL,https://ctdbase.org/detail.go?type=gene&acc=431705,,,431705.0,ASTL,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ASTL mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
296,300760,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,431705,ASTL,https://ctdbase.org/detail.go?type=gene&acc=431705,,,431705.0,ASTL,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of ASTL mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
297,300761,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATAD2 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
298,300762,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATF3 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
299,300763,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,491,ATP2B2,https://ctdbase.org/detail.go?type=gene&acc=491,,,491.0,ATP2B2,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATP2B2 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
300,300764,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,93974,ATP5IF1,https://ctdbase.org/detail.go?type=gene&acc=93974,,,93974.0,ATP5IF1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATP5IF1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
301,300765,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,518,ATP5MC3,https://ctdbase.org/detail.go?type=gene&acc=518,,,518.0,ATP5MC3,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATP5MC3 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
302,300766,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,92270,ATP6AP1L,https://ctdbase.org/detail.go?type=gene&acc=92270,,,92270.0,ATP6AP1L,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATP6AP1L mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
303,300767,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,245972,ATP6V0D2,https://ctdbase.org/detail.go?type=gene&acc=245972,,,245972.0,ATP6V0D2,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of ATP6V0D2 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
304,300768,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,245973,ATP6V1C2,https://ctdbase.org/detail.go?type=gene&acc=245973,,,245973.0,ATP6V1C2,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of ATP6V1C2 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
305,301129,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,22893,BAHD1,https://ctdbase.org/detail.go?type=gene&acc=22893,,,22893.0,BAHD1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of BAHD1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
306,301130,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,8538,BARX2,https://ctdbase.org/detail.go?type=gene&acc=8538,,,8538.0,BARX2,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of BARX2 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
307,301131,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Indole-3-carbinol results in increased expression of BAX,,,PMID:16082211,https://www.ncbi.nlm.nih.gov/pubmed/16082211,16082211,,
308,301132,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Indole-3-carbinol results in increased expression of BAX protein,,,PMID:29775573,https://www.ncbi.nlm.nih.gov/pubmed/29775573,29775573,,
309,301133,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,80127,BBOF1,https://ctdbase.org/detail.go?type=gene&acc=80127,,,80127.0,BBOF1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of BBOF1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
310,303747,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,9606.0,Homo sapiens (human),Indole-3-carbinol results in increased expression of CDKN1B,,,PMID:16082211,https://www.ncbi.nlm.nih.gov/pubmed/16082211,16082211,,
311,303748,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1030,CDKN2B,https://ctdbase.org/detail.go?type=gene&acc=1030,,,1030.0,CDKN2B,9606.0,Homo sapiens (human),Indole-3-carbinol results in increased expression of CDKN2B,,,PMID:16082211,https://www.ncbi.nlm.nih.gov/pubmed/16082211,16082211,,
312,303928,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,64105,CENPK,https://ctdbase.org/detail.go?type=gene&acc=64105,,,64105.0,CENPK,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CENPK mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
313,303929,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,91687,CENPL,https://ctdbase.org/detail.go?type=gene&acc=91687,,,91687.0,CENPL,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CENPL mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
314,303930,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,79959,CEP76,https://ctdbase.org/detail.go?type=gene&acc=79959,,,79959.0,CEP76,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CEP76 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
315,303931,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,51134,CEP83,https://ctdbase.org/detail.go?type=gene&acc=51134,,,51134.0,CEP83,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CEP83 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
316,303932,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,91012,CERS5,https://ctdbase.org/detail.go?type=gene&acc=91012,,,91012.0,CERS5,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CERS5 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
317,303933,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,10087,CERT1,https://ctdbase.org/detail.go?type=gene&acc=10087,,,10087.0,CERT1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CERT1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
318,303934,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,234671,CES2C,https://ctdbase.org/detail.go?type=gene&acc=234671,,,234671.0,Ces2c,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CES2C mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
319,303935,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,234671,CES2C,https://ctdbase.org/detail.go?type=gene&acc=234671,,,234671.0,Ces2c,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CES2C mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
320,304113,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,8837,CFLAR,https://ctdbase.org/detail.go?type=gene&acc=8837,,,8837.0,CFLAR,9606.0,Homo sapiens (human),Indole-3-carbinol results in decreased expression of CFLAR,,,PMID:16082211,https://www.ncbi.nlm.nih.gov/pubmed/16082211,16082211,,
321,304114,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,84303,CHCHD6,https://ctdbase.org/detail.go?type=gene&acc=84303,,,84303.0,CHCHD6,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CHCHD6 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
322,304115,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,84303,CHCHD6,https://ctdbase.org/detail.go?type=gene&acc=84303,,,84303.0,CHCHD6,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CHCHD6 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
323,304116,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CHEK1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
324,304117,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CHEK1 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
325,304118,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CHEK2 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
326,302354,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,64754,SMYD3,https://ctdbase.org/detail.go?type=gene&acc=64754,,,64754.0,SMYD3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in decreased expression of SMYD3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
327,302355,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,114826,SMYD4,https://ctdbase.org/detail.go?type=gene&acc=114826,,,114826.0,SMYD4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SMYD4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
328,302356,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10302,SNAPC5,https://ctdbase.org/detail.go?type=gene&acc=10302,,,10302.0,SNAPC5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SNAPC5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
329,302357,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23642,SNHG1,https://ctdbase.org/detail.go?type=gene&acc=23642,,,23642.0,SNHG1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SNHG1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
330,302358,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,84973,SNHG7,https://ctdbase.org/detail.go?type=gene&acc=84973,,,84973.0,SNHG7,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SNHG7 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
331,302359,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79753,SNIP1,https://ctdbase.org/detail.go?type=gene&acc=79753,,,79753.0,SNIP1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SNIP1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
332,302689,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2059,EPS8,https://ctdbase.org/detail.go?type=gene&acc=2059,,,2059.0,EPS8,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EPS8 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of EPS8 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
333,302690,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,26284,ERAL1,https://ctdbase.org/detail.go?type=gene&acc=26284,,,26284.0,ERAL1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
334,302691,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2064,ERBB2,https://ctdbase.org/detail.go?type=gene&acc=2064,,,2064.0,ERBB2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERBB2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
335,302692,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2072,ERCC4,https://ctdbase.org/detail.go?type=gene&acc=2072,,,2072.0,ERCC4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
336,302864,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2079,ERH,https://ctdbase.org/detail.go?type=gene&acc=2079,,,2079.0,ERH,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERH mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
337,302865,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79033,ERI3,https://ctdbase.org/detail.go?type=gene&acc=79033,,,79033.0,ERI3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERI3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
338,302866,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,11160,ERLIN2,https://ctdbase.org/detail.go?type=gene&acc=11160,,,11160.0,ERLIN2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ERLIN2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
339,302867,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,55780,ERMARD,https://ctdbase.org/detail.go?type=gene&acc=55780,,,55780.0,ERMARD,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ERMARD mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
340,302868,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79956,ERMP1,https://ctdbase.org/detail.go?type=gene&acc=79956,,,79956.0,ERMP1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ERMP1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
341,302869,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2081,ERN1,https://ctdbase.org/detail.go?type=gene&acc=2081,,,2081.0,ERN1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ERN1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
342,302870,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,30001,ERO1A,https://ctdbase.org/detail.go?type=gene&acc=30001,,,30001.0,ERO1A,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ERO1A mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
343,302871,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,30001,ERO1A,https://ctdbase.org/detail.go?type=gene&acc=30001,,,30001.0,ERO1A,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of ERO1A mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
344,304437,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3995,FADS3,https://ctdbase.org/detail.go?type=gene&acc=3995,,,3995.0,FADS3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of FADS3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
345,453009,3922,Comparative Toxicogenomics Database (CTD),"6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid",C095104,LG 100268,https://ctdbase.org/detail.go?type=chem&acc=C095104,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),LG 100268 results in increased expression of SCD1 mRNA,,,PMID:30027469,https://www.ncbi.nlm.nih.gov/pubmed/30027469,30027469,,
346,453010,3922,Comparative Toxicogenomics Database (CTD),"6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid",C095104,LG 100268,https://ctdbase.org/detail.go?type=chem&acc=C095104,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,10090.0,Mus musculus (house mouse),[[dexamethasone co-treated with INS protein co-treated with 1-methyl-3-isobutylxanthine] co-treated with LG 100268] results in increased expression of SLC27A1 mRNA,,,PMID:10777552,https://www.ncbi.nlm.nih.gov/pubmed/10777552,10777552,,
347,377331,5035,IUPHAR/BPS Guide to PHARMACOLOGY,Raloxifene,2820,raloxifene,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820,3186,aldehyde oxidase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3186,Q06278,Aldehyde oxidase,316.0,AOX1,9606.0,Homo sapiens (human),Inhibition,pIC50,7.35,,,,,
348,377332,5035,BindingDB,Raloxifene,19441,2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19441,4399,Phospholipase D1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4399,Q13393,Phospholipase D1,5337.0,PLD1,9606.0,Homo sapiens (human),,IC50 (nM),4300.0,PMID:19136975|DOI:10.1038/nchembio.140,https://www.ncbi.nlm.nih.gov/pubmed/19136975|https://doi.org/10.1038/nchembio.140,19136975,10.1038/nchembio.140,
349,302029,5206,ChEMBL,Sevoflurane,CHEMBL1200694,SEVOFLURANE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200694/,CHEMBL2331042,Potassium channel subfamily K member 18,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331042/,Q7Z418,Potassium channel subfamily K member 18,338567.0,KCNK18,9606.0,Homo sapiens (human),Potassium channel subfamily K member 18 opener,,,PMID:16402123|PMID:21788314|PMID:22226507,https://www.ncbi.nlm.nih.gov/pubmed/16402123|https://www.ncbi.nlm.nih.gov/pubmed/21788314|https://www.ncbi.nlm.nih.gov/pubmed/22226507,16402123|21788314|22226507,,
350,302030,5208,BindingDB,C.I. Natural Red 20,178090,"5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=178090,384,Amine oxidase [flavin-containing] A,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=384,P21397,Amine oxidase [flavin-containing] A,4128.0,MAOA,9606.0,Homo sapiens (human),,IC50 (nM),1500.0,PMID:26684482|DOI:10.1111/cbdd.12708,https://www.ncbi.nlm.nih.gov/pubmed/26684482|https://doi.org/10.1111/cbdd.12708,26684482,10.1111/cbdd.12708,
351,302031,5208,BindingDB,C.I. Natural Red 20,178090,"5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=178090,7683,Amine oxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7683,,,,,,,,IC50 (nM),1010.0,PMID:26684482|DOI:10.1111/cbdd.12708,https://www.ncbi.nlm.nih.gov/pubmed/26684482|https://doi.org/10.1111/cbdd.12708,26684482,10.1111/cbdd.12708,
352,302032,5235,DrugBank,Sodium Fluoride,DB09325,Sodium fluoride,https://www.drugbank.ca/drugs/DB09325,BE0004122,Enolase-phosphatase E1,https://www.drugbank.ca/bio_entities/BE0004122,Q9UHY7,Enolase-phosphatase E1,58478.0,ENOPH1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:16411755|PMID:24757316,https://www.ncbi.nlm.nih.gov/pubmed/16411755|https://www.ncbi.nlm.nih.gov/pubmed/24757316,16411755|24757316,,
353,302033,5235,DrugBank,Sodium Fluoride,DB09325,Sodium fluoride,https://www.drugbank.ca/drugs/DB09325,BE0009702,Enolase,https://www.drugbank.ca/bio_entities/BE0009702,B3WCW7,Enolase,,,543734.0,Lacticaseibacillus casei BL23,Inhibitor,,,PMID:2179328|PMID:28808691,https://www.ncbi.nlm.nih.gov/pubmed/2179328|https://www.ncbi.nlm.nih.gov/pubmed/28808691,2179328|28808691,,
354,302034,5235,DrugBank,Sodium Fluoride,DB09325,Sodium fluoride,https://www.drugbank.ca/drugs/DB09325,BE0009703,Enolase,https://www.drugbank.ca/bio_entities/BE0009703,A3CMA7,Enolase,61536183.0,eno,388919.0,Streptococcus sanguinis SK36,Inhibitor,,,PMID:28808691,https://www.ncbi.nlm.nih.gov/pubmed/28808691,28808691,,
355,302035,5241,DrugBank,Ipodate,DB09333,Iopodic acid,https://www.drugbank.ca/drugs/DB09333,BE0009333,Thyroxine 5-deiodinase,https://www.drugbank.ca/bio_entities/BE0009333,P55073,Thyroxine 5-deiodinase,1735.0,DIO3,9606.0,Homo sapiens (human),Antagonist,,,PMID:1687043|PMID:7608275,https://www.ncbi.nlm.nih.gov/pubmed/1687043|https://www.ncbi.nlm.nih.gov/pubmed/7608275,1687043|7608275,,
356,302036,5241,DrugBank,Ipodate,DB09333,Iopodic acid,https://www.drugbank.ca/drugs/DB09333,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Substrate,,,PMID:20641974,https://www.ncbi.nlm.nih.gov/pubmed/20641974,20641974,,
357,304262,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,8532,CPZ,https://ctdbase.org/detail.go?type=gene&acc=8532,,,8532.0,CPZ,10090.0,Mus musculus (house mouse),Sulforaphane results in increased expression of CPZ mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
358,304263,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1379,CR1L,https://ctdbase.org/detail.go?type=gene&acc=1379,,,1379.0,CR1L,9606.0,Homo sapiens (human),Sulforaphane results in increased expression of CR1L mRNA,,,PMID:26833863,https://www.ncbi.nlm.nih.gov/pubmed/26833863,26833863,,
359,377330,5533,Drug Gene Interaction database (DGIdb),Trazodone,,TRAZODONE,https://www.dgidb.org/drugs/rxcui:10737,,HTR1A,https://www.dgidb.org/genes/hgnc:5286,,,3350.0,HTR1A,9606.0,Homo sapiens (human),,,,,,,,
360,853995,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7515,XRCC1,https://ctdbase.org/detail.go?type=gene&acc=7515,,,7515.0,XRCC1,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of XRCC1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
361,853996,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,27198,HCAR1,https://ctdbase.org/detail.go?type=gene&acc=27198,,,27198.0,HCAR1,9606.0,Homo sapiens (human),Bis(4-hydroxyphenyl)sulfone results in increased expression of HCAR1 mRNA,,,PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/27685785,27685785,,
362,853997,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,3054,HCFC1,https://ctdbase.org/detail.go?type=gene&acc=3054,,,3054.0,HCFC1,10090.0,Mus musculus (house mouse),Bis(4-hydroxyphenyl)sulfone results in increased methylation of HCFC1 exon,,,PMID:33297965,https://www.ncbi.nlm.nih.gov/pubmed/33297965,33297965,,
363,853998,6626,Comparative Toxicogenomics Database (CTD),"4,4'-Sulfonyldiphenol",C543008,bis(4-hydroxyphenyl)sulfone,https://ctdbase.org/detail.go?type=chem&acc=C543008,54985,HCFC1R1,https://ctdbase.org/detail.go?type=gene&acc=54985,,,54985.0,HCFC1R1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HCFC1R1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
364,865400,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10093,ARPC4,https://ctdbase.org/detail.go?type=gene&acc=10093,,,10093.0,ARPC4,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of ARPC4 mRNA,,,PMID:33387578|PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/33387578|https://www.ncbi.nlm.nih.gov/pubmed/34747641,33387578|34747641,,
365,1404562,104850,Comparative Toxicogenomics Database (CTD),Rimonabant,D000077285,Rimonabant,https://ctdbase.org/detail.go?type=chem&acc=D000077285,51316,PLAC8,https://ctdbase.org/detail.go?type=gene&acc=51316,,,51316.0,PLAC8,10090.0,Mus musculus (house mouse),Rimonabant inhibits the reaction [dietary fats results in decreased expression of PLAC8 mrna],,,PMID:19030233,https://www.ncbi.nlm.nih.gov/pubmed/19030233,19030233,,
